Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Ricaurte

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Neurotoxicity Research|April 28, 2004
Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neuronsG A Ricaurte, U D McCann
Journal of Clinical Psychopharmacology|June 1, 1993
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidenceU D McCann, G A Ricaurte
Neuroreport|October 6, 1998
Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicityB T Callahan, G A Ricaurte
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 15, 1999
Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recoveryG Hatzidimitriou, U D McCann, G A Ricaurte
European Journal of Pharmacology|September 5, 1995
Fenfluramine's appetite suppression and serotonin neurotoxicity are separableU D McCann, J Yuan, G A Ricaurte
European Journal of Pharmacology|September 26, 1996
Prolactin response to fenfluramine is independent of serotonin releaseU D McCann, G Hatzidimitriou, G A Ricaurte
Synapse (New York, N.Y.)|October 25, 2000
Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermineB T Callahan, J Yuan, G A Ricaurte
Neuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animalsG A Ricaurte, J Yuan, U D McCann
Pharmacology & Therapeutics|January 1, 1987
Neurotoxins, parkinsonism and Parkinson's diseaseJ W Langston, I Irwin, G A Ricaurte
Neuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studiesU D McCann, V Eligulashvili, G A Ricaurte
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Neurotoxicity Research|April 28, 2004
Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neuronsG A Ricaurte, U D McCann
Journal of Clinical Psychopharmacology|June 1, 1993
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidenceU D McCann, G A Ricaurte
Neuroreport|October 6, 1998
Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicityB T Callahan, G A Ricaurte
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 15, 1999
Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recoveryG Hatzidimitriou, U D McCann, G A Ricaurte
European Journal of Pharmacology|September 5, 1995
Fenfluramine's appetite suppression and serotonin neurotoxicity are separableU D McCann, J Yuan, G A Ricaurte
European Journal of Pharmacology|September 26, 1996
Prolactin response to fenfluramine is independent of serotonin releaseU D McCann, G Hatzidimitriou, G A Ricaurte
Synapse (New York, N.Y.)|October 25, 2000
Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermineB T Callahan, J Yuan, G A Ricaurte
Neuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animalsG A Ricaurte, J Yuan, U D McCann
Pharmacology & Therapeutics|January 1, 1987
Neurotoxins, parkinsonism and Parkinson's diseaseJ W Langston, I Irwin, G A Ricaurte
Neuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studiesU D McCann, V Eligulashvili, G A Ricaurte
Pageof 11